Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

280 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and safety of lactosaminated human serum albumin-adenine arabinoside monophosphate in chronic hepatitis B patients non-responders to interferon therapy: a randomised clinical trial.
Zarski JP, Barange K, Souvignet C, Bertini M, Marcellin P, Tran A, Deugnier Y, Couzigou P, Plages A, Ambroise-Thomas P. Zarski JP, et al. J Hepatol. 2001 Mar;34(3):486-8. doi: 10.1016/s0168-8278(01)00018-6. J Hepatol. 2001. PMID: 11322216 Clinical Trial. No abstract available.
Better efficacy of a 12-month interferon alfa-2b retreatment in patients with chronic hepatitis C relapsing after a 6-month treatment: a multicenter, controlled, randomized trial. Le Groupe D'étude et De Traitement du Virus De L'hépatite C (Get.Vhc).
Payen JL, Izopet J, Galindo-Migeot V, Lauwers-Cances V, Zarski JP, Seigneurin JM, Dussaix E, Voigt JJ, Selves J, Barange K, Puel J, Pascal JP. Payen JL, et al. Among authors: zarski jp. Hepatology. 1998 Dec;28(6):1680-6. doi: 10.1002/hep.510280631. Hepatology. 1998. PMID: 9828235 Clinical Trial.
Ribavirin quantification in combination treatment of chronic hepatitis C.
Larrat S, Stanke-Labesque F, Plages A, Zarski JP, Bessard G, Souvignet C. Larrat S, et al. Among authors: zarski jp. Antimicrob Agents Chemother. 2003 Jan;47(1):124-9. doi: 10.1128/AAC.47.1.124-129.2003. Antimicrob Agents Chemother. 2003. PMID: 12499179 Free PMC article.
[Physiopathology of HCV infection].
Zarski JP, Souvignet C. Zarski JP, et al. Gastroenterol Clin Biol. 2002 Apr;26 Spec No 2:B154-62. Gastroenterol Clin Biol. 2002. PMID: 12180283 Review. French. No abstract available.
Safety and efficacy of daclatasvir-sofosbuvir in HCV genotype 1-mono-infected patients.
Pol S, Bourliere M, Lucier S, Hezode C, Dorival C, Larrey D, Bronowicki JP, Ledinghen VD, Zoulim F, Tran A, Metivier S, Zarski JP, Samuel D, Guyader D, Marcellin P, Minello A, Alric L, Thabut D, Chazouilleres O, Riachi G, Bourcier V, Mathurin P, Loustaud-Ratti V, D'Alteroche L, Fouchard-Hubert I, Habersetzer F, Causse X, Geist C, Rosa I, Gournay J, Saillard E, Billaud E, Petrov-Sanchez V, Diallo A, Fontaine H, Carrat F; ANRS/AFEF HEPATHER study group. Pol S, et al. Among authors: zarski jp. J Hepatol. 2017 Jan;66(1):39-47. doi: 10.1016/j.jhep.2016.08.021. Epub 2016 Sep 10. J Hepatol. 2017. PMID: 27622858 Free article.
280 results